Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Alternate Health Club vs Wisp

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.3

Alternate Health Club

Best for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platform
★★★3.7

Starting at $129/mo

CompoundedSemaglutideTirzepatideLegitScript Verified
Visit Alternate Health Club
7.0

Wisp

Best for buyers who want a board-certified telehealth platform offering both branded injectables AND a sublingual alternative — with full disclosure that the sublingual form is not human-tested
★★★3.5

Starting at $225/mo

Brand WegovyBrand ZepboundBrand SaxendaCompounded Sublingual Semaglutide
Visit Wisp

Side-by-Side Comparison

FeatureAlternate Health ClubWisp
Overall Score7.3/107.0/10
Starting Price$129/mo$225/mo
Editorial Rating3.7 ★ /53.5 ★ /5
Features6 features6 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Alternate Health Club

Pros

  • $129/month compounded semaglutide is in the cheapest decile of the US compounded telehealth market
  • $169/month compounded tirzepatide is competitive with established compounded-tirz platforms
  • Complimentary workout & dietary plans included alongside medication — most peer platforms don't bundle this
  • LegitScript Verified seal displayed in the footer
  • U.S.-licensed clinicians explicitly mentioned

Cons

  • Parent company / legal entity name NOT publicly disclosed — material YMYL transparency gap
  • State of incorporation NOT disclosed
  • Per-state availability NOT enumerated — verify your state ships before committing
  • Pharmacy partners NOT publicly named — material YMYL transparency gap
  • Lab work NOT clearly disclosed as included
  • Billing cadence (monthly vs quarterly vs annual) NOT clearly disclosed on home page
  • First-month discount or trial offer NOT disclosed

Wisp

Pros

  • Wider GLP-1 menu than the prior stub suggested — both branded injectables (Wegovy, Zepbound, Saxenda) AND the compounded sublingual option
  • LegitScript certified, board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC publicly named)
  • Wisp's product page uses appropriately cautious language around sublingual: 'lab tests using human-derived tissues suggest it may begin working' and 'effectiveness in patients may vary' — disclosure is more rigorous than most compounded GLP-1 marketing

Cons

  • EFFECTIVENESS CAVEAT: sublingual compounded semaglutide has not been tested in humans — Wisp's own product page explicitly states this. Injectables (Wegovy, Zepbound, Saxenda) on the same platform have FDA safety/efficacy data; sublingual does not.
  • Pharmacy partners not publicly named
  • States served list not publicly enumerated

Our Verdict

Winner: Alternate Health ClubScore: 7.3/10

Alternate Health Club edges out Wisp with a higher overall score of 7.3/10 and is particularly strong for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platform. Wisp remains a solid alternative, especially if you're looking for buyers who want a board-certified telehealth platform offering both branded injectables AND a sublingual alternative — with full disclosure that the sublingual form is not human-tested.

Glossary references

Key terms in this article, linked to their canonical definitions.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.